The Effect of Ferric Citrate on Inflammation and Lipid Levels in Patients on Hemodialysis

Trial Profile

The Effect of Ferric Citrate on Inflammation and Lipid Levels in Patients on Hemodialysis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Jan 2018

At a glance

  • Drugs Ferric citrate (Primary)
  • Indications Hyperphosphataemia
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 04 Jan 2018 New trial record
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top